Want to join the conversation?
$ABBV 2Q15 Call: Adjusted earnings per share of a dollar $0.08, representing a growth of more than 31% vs. 2Q14. Our results included strong operational sales growth of nearly 20% driven by a number of products across our portfolio, including strong performance from our newly acquired oncology therapy Imbruvica.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!